DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Goss PE, Smith IE, O’Shaughnessy J. et al. TEACH investigators.
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial.
Lancet Oncol 2013;
14 (01) 88-96
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.